» Articles » PMID: 21128819

Selection of Treatment Among Latina and Non-Latina White Women with Ductal Carcinoma in Situ

Overview
Date 2010 Dec 7
PMID 21128819
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The growing rates of ductal carcinoma in situ (DCIS) and evidence that Latinas may underuse breast-conserving surgery (BCS) compared with white women highlight the need to better understand how treatment decisions are made in this understudied group. To help address this gap, this study compared surgery and radiation treatment decision making among white and Spanish-speaking and English-speaking Latina women with DCIS recruited from eight population-based cancer registries from 35 California counties.

Methods: Women aged ≥18 who self-identified as Latina or non-Latina white diagnosed with DCIS between 2002 and 2005 were selected from eight California Cancer Registry (CCR) regions and surveyed about their DCIS treatment decision making by telephone approximately 24 months after diagnosis. Survey data were merged with CCR hospital-based records to obtain tumor and treatment data.

Results: Mean age was 57 years. Multivariate analysis indicated no differences by ethnicity or language in the receipt of mastectomy vs. BCS after controlling demographic, health, and personal preferences. English-speaking Latinas were more likely to receive radiation than their Spanish-speaking or white counterparts, controlling for demographic and other factors. Among women receiving BCS, physician recommendation was the strongest predictor of receipt of radiation.

Conclusions: Ethnic disparities in surgical treatment choices after breast cancer diagnosis were not seen in this cohort of women diagnosed with DCIS. Physicians play an essential role in patients' treatment choices for DCIS, particularly for adjuvant radiation.

Citing Articles

Factors influencing the initiation of adjuvant endocrine therapy in patients with estrogen receptor-positive ductal carcinoma in situ: a single institution experience.

Levy J, Farag F, Cole J Breast Cancer Res Treat. 2022; 196(1):207-213.

PMID: 36083381 PMC: 9550728. DOI: 10.1007/s10549-022-06735-9.


Prostate cancer patients' self-reported participation in research: an examination of racial/ethnic disparities.

Palmer N, Borno H, Gregorich S, Livaudais-Toman J, Kaplan C Cancer Causes Control. 2021; 32(10):1161-1172.

PMID: 34189651 PMC: 8416807. DOI: 10.1007/s10552-021-01463-9.


Impact of acculturation on breast cancer treatment and survivorship care among Mexican American patients in Texas.

Advani P, Bondy M, Thompson P, Martinez M, Nodora J, Vernon S J Cancer Surviv. 2018; 12(5):659-668.

PMID: 30043339 PMC: 6436629. DOI: 10.1007/s11764-018-0703-y.


Interventions are needed to support patient-provider decision-making for DCIS: a scoping review.

Kim C, Liang L, Wright F, Look Hong N, Groot G, Helyer L Breast Cancer Res Treat. 2017; 168(3):579-592.

PMID: 29273956 PMC: 5842253. DOI: 10.1007/s10549-017-4613-x.


Treatment experiences of Latinas after diagnosis of breast cancer.

Katz S, Wallner L, Abrahamse P, Janz N, Martinez K, Shumway D Cancer. 2017; 123(16):3022-3030.

PMID: 28398629 PMC: 5544545. DOI: 10.1002/cncr.30702.


References
1.
Legorreta A, Liu X, Parker R . Examining the use of breast-conserving treatment for women with breast cancer in a managed care environment. Am J Clin Oncol. 2000; 23(5):438-41. DOI: 10.1097/00000421-200010000-00002. View

2.
Satariano E, Swanson G, Moll P . Nonclinical factors associated with surgery received for treatment of early-stage breast cancer. Am J Public Health. 1992; 82(2):195-8. PMC: 1694287. DOI: 10.2105/ajph.82.2.195. View

3.
Guadagnoli E, Weeks J, Shapiro C, Gurwitz J, Borbas C, Soumerai S . Use of breast-conserving surgery for treatment of stage I and stage II breast cancer. J Clin Oncol. 1998; 16(1):101-6. DOI: 10.1200/JCO.1998.16.1.101. View

4.
Jones J . Overdiagnosis and overtreatment of breast cancer: progression of ductal carcinoma in situ: the pathological perspective. Breast Cancer Res. 2006; 8(2):204. PMC: 1557717. DOI: 10.1186/bcr1397. View

5.
Hillner B, Desch C, Carlson R, Smith T, Esserman L, Bear H . Trade-offs between survival and breast preservation for three initial treatments of ductal carcinoma-in-situ of the breast. J Clin Oncol. 1996; 14(1):70-7. DOI: 10.1200/JCO.1996.14.1.70. View